|

Avoiding Pitfalls and Mitigating Risk Throughout a Clinical Trial

Monday, June 4; 3 PM – 4 PM
Moderator: Frank Jaskulke, VP of Intelligence (MAA)
Speakers: Angela Mallery, Senior Product Development Strategist, NAMSA
Philippe Kassab, President, genae Americas

Description
Study sponsors often face budget and time constraints during trial startup which can lead to poor decisions that ultimately will affect a study long after the startup phase. This session will discuss common pitfalls and present best practices on how to mitigate risk throughout a medical device clinical trial.